Gitlab Inc (NASDAQ: GTLB) has potential for growth due to demand for cloud and GenAI apps. Analyst initiates coverage with Buy rating and target of $58.

GitLab and IBM are expanding their partnership to bridge mainframe and cloud-native development with seamless integration, CI/CD runner support, end-to-end visibility, and cost efficiency. GitLab and ...

The investment firm came out incrementally positive on GitLab’s long-term market potential following a meeting with CEO Bill ...

UnitedHealth extended its 15-year earnings beat streak in 2024 with $3.3 billion in asset sales, raising questions about ...

Proper handling of continuous variables is crucial in healthcare research, for example, within regression modelling for descriptive, explanatory, or predictive purposes. However, inadequate methods ...